Focus: Lilly weight-loss pill could be FDA-approved by year-end

Focus: Lilly weight-loss pill could be FDA-approved by year-end

LLY
Negative
Market

Summary

Eli Lilly 's experimental weight-loss pill could be fast-tracked under a one- to two-month review process recently launc...

Eli Lilly 's experimental weight-loss pill could be fast-tracked under a one- to two-month review process recently launched by the U.S. Food and Drug Administration, several Wall Street analysts said.

Related Articles
Lilly's Kisunla (donanemab) receives marketing authorization by European Commission for the treatment of early symptomatic Alzheimer's disease
LLY
Positive
3 Dividend Growth Stocks You Can Buy and Forget About
LLY
Positive
Lilly sees obesity drug leadership beyond US as it leans on consumer-focused strategy
LLY
Neutral